Mgso4 in organophosphate poisoning?
Reading File
Finding Sources
Searching PubMed
magnesium sulfate organophosphate poisoning
Reading File
Reading Article
Finding Sources
Reading File
Reading File
Reading File
I now have a clear, well-sourced picture. Here is the complete answer:
MgSO4 in Organophosphate (OP) Poisoning
Rationale / Why it's considered
OP compounds inhibit acetylcholinesterase, causing acetylcholine accumulation at muscarinic and nicotinic receptors. This leads to:
- Excess catecholamine release (nicotinic effect) -> prolonged QTc interval
- Risk of ventricular arrhythmias, particularly torsades de pointes (TdP)
- Massive presynaptic acetylcholine release that can be modulated by magnesium (which blocks voltage-gated calcium channels and reduces neurotransmitter release)
MgSO4 is hypothesized to work by:
- Membrane stabilization - reduces excitability of the myocardium and nerve terminals
- Reducing ACh release - blocks presynaptic Ca²⁺-dependent neurotransmitter release
- Anti-arrhythmic effect - corrects QTc prolongation and reduces risk of TdP
- Atropine-sparing - decreasing muscarinic overstimulation may reduce the total atropine dose needed
Current Evidence (2025 Meta-Analysis)
A systematic review and meta-analysis of 8 RCTs (n = 549) published in Clinical Toxicology (2025) - PMID 40792609 - found:
| Outcome | Result |
|---|---|
| Mortality | Risk ratio 0.37 (95% CI: 0.22-0.64) - significant reduction |
| Atropine requirements | Mean difference -23.27 mg/day (95% CI: -36.57 to -9.97) - significant reduction |
| Hospital length of stay | No significant difference |
| Need for mechanical ventilation | No significant difference |
| Safety | Favorable; only transient hypotension reported at higher infusion rates |
This is promising, but the studies have small sample sizes and methodological limitations. Larger RCTs are needed.
Textbook Position
-
Tintinalli's Emergency Medicine: "Although there is some evidence for the benefit of magnesium sulfate and calcium channel blockers in the treatment of organophosphate poisoning, they are not yet recommended for routine clinical use." (Tintinalli's Emergency Medicine, block 16)
-
Goldman-Cecil Medicine: Lists MgSO4 as part of treatment - "atropine (1-2 mg IV bolus, doubled every 5 minutes) and magnesium sulfate (4 g IV over 30 minutes)" as a management option for OP poisoning (Goldman-Cecil Medicine, block 56)
Proposed Protocol (where used)
- Dose: MgSO4 4 g IV over 20-30 minutes as loading dose
- Indication: Moderate-to-severe acute OP insecticide poisoning
- Adjunct to, not replacement for: Atropine + oximes (pralidoxime/obidoxime) + supportive care
- Monitoring: Serum Mg levels, DTRs, respiratory rate, BP (risk of transient hypotension)
Important Cautions
| Concern | Detail |
|---|---|
| Respiratory depression | Mg potentiates neuromuscular blockade; OP already causes respiratory failure - use caution |
| Hypotension | Especially at rapid infusion rates |
| Not standard of care | Not included in WHO or most national OP management guidelines |
| Evidence quality | All 8 RCTs had small sample sizes and were mostly from South/Southeast Asia; may not generalize broadly |
Summary
MgSO4 is an investigational adjunct in OP poisoning - not a routine recommendation. The 2025 meta-analysis shows a significant reduction in mortality (RR 0.37) and atropine requirements, which is compelling, but the evidence base remains limited. Standard therapy remains atropine titrated to drying of secretions + pralidoxime + airway support. MgSO4 may be considered as an add-on in severe cases, particularly where QTc prolongation and arrhythmia risk are prominent concerns.
Evidence update note: The 2025 meta-analysis (PMID 40792609) suggests MgSO4 may reduce mortality and atropine needs, which is more favorable than what older textbooks state. The current textbook guidance (not for routine use) may be revised as evidence matures.
This is a shared conversation. Sign in to Orris to start your own chat.